Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144554 · ClinicalTrials.gov registry record
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
A clinical trial of Type 1 Diabetes, sponsored by Insulet Corporation.
- Recruiting
- Registry status
- 2,200
- Enrollment target
- 1
- Study location
NCT06144554 is a study of Type 1 Diabetes that is actively recruiting participants, run by Insulet Corporation. The registered enrollment target is 2,200 participants, above the 812-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (171% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06144554, a study of Type 1 Diabetes, is actively recruiting participants, sponsored by Insulet Corporation.
- RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
Conditions Studied
Interventions
- DEVICE Omnipod 5
Study Locations (1)
New York
- Circuit Clinical - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2027-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06144554
The ClinicalTrials.gov registry entry for NCT06144554 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 812-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (171% higher). The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Omnipod 5 is the first listed.
NCT06144554 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06144554 about?
NCT06144554 is a clinical study titled "Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes". This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
What is the current status of trial NCT06144554?
This trial is currently recruiting. The enrollment target is 2,200 participants. The study started on 2023-09-25. Estimated completion is 2027-09.
What conditions does trial NCT06144554 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT06144554?
The interventions under investigation include: Omnipod 5 (DEVICE).
Who is sponsoring clinical trial NCT06144554?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06144554 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.